The Lancet: November 22, 2012

The Lancet in conversation with - A podcast by The Lancet Group - Fridays

Categories:

Education

David Cunningham from the Royal Marsden Hospital in London assesses the potential of regorafenib in the treatment of colorectal cancer and gastrointestinal stromal tumours.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv